Literature DB >> 26525881

TCF7L2 Genotype and α-Cell Function in Humans Without Diabetes.

Meera Shah1, Ron T Varghese1, John M Miles1, Francesca Piccinini2, Chiara Dalla Man2, Claudio Cobelli2, Kent R Bailey3, Robert A Rizza1, Adrian Vella4.   

Abstract

The diabetes-associated allele in TCF7L2 increases the rate of conversion to diabetes; however, the mechanism by which this occurs remains elusive. We hypothesized that the diabetes-associated allele in this locus (rs7903146) impairs insulin secretion and that this defect would be exacerbated by acute free fatty acid (FFA)-induced insulin resistance. We studied 120 individuals of whom one-half were homozygous for the diabetes-associated allele TT at rs7903146 and one-half were homozygous for the protective allele CC. After a screening examination during which glucose tolerance status was determined, subjects were studied on two occasions in random order while undergoing an oral challenge. During one study day, FFA was elevated by infusion of Intralipid plus heparin. On the other study day, subjects received the same amount of glycerol as present in the Intralipid infusion. β-Cell responsivity indices were estimated with the oral C-peptide minimal model. We report that β-cell responsivity was slightly impaired in the TT genotype group. Moreover, the hyperbolic relationship between insulin secretion and β-cell responsivity differed significantly between genotypes. Subjects also exhibited impaired suppression of glucagon after an oral challenge. These data imply that a genetic variant harbored within the TCF7L2 locus impairs glucose tolerance through effects on glucagon as well as on insulin secretion.
© 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26525881      PMCID: PMC4747457          DOI: 10.2337/db15-1233

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  48 in total

1.  Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.

Authors:  P Shah; A Vella; A Basu; R Basu; W F Schwenk; R A Rizza
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

2.  Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method.

Authors:  Chiara Dalla Man; Andrea Caumo; Rita Basu; Robert Rizza; Gianna Toffolo; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-05-11       Impact factor: 4.310

3.  Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.

Authors:  Gerlies Bock; Chiara Dalla Man; Marco Campioni; Elizabeth Chittilapilly; Rita Basu; Gianna Toffolo; Claudio Cobelli; Robert Rizza
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

4.  Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance.

Authors:  Coleen M Damcott; Toni I Pollin; Laurie J Reinhart; Sandra H Ott; Haiqing Shen; Kristi D Silver; Braxton D Mitchell; Alan R Shuldiner
Journal:  Diabetes       Date:  2006-09       Impact factor: 9.461

5.  Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients.

Authors:  P C Butler; R A Rizza
Journal:  Diabetes       Date:  1991-01       Impact factor: 9.461

Review 6.  Fatty acid signaling in the beta-cell and insulin secretion.

Authors:  Christopher J Nolan; Murthy S R Madiraju; Viviane Delghingaro-Augusto; Marie-Line Peyot; Marc Prentki
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

Review 7.  Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.

Authors:  G Boden
Journal:  Diabetes       Date:  1997-01       Impact factor: 9.461

8.  Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man.

Authors:  W Waldhäusl; P Bratusch-Marrain; S Gasic; A Korn; P Nowotny
Journal:  Diabetologia       Date:  1979-10       Impact factor: 10.122

9.  Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele.

Authors:  K Færch; K Pilgaard; F K Knop; T Hansen; O Pedersen; T Jørgensen; J J Holst
Journal:  Diabetes Obes Metab       Date:  2012-09-09       Impact factor: 6.577

10.  Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.

Authors:  Kirsten Vollmer; Jens J Holst; Birgit Baller; Mark Ellrichmann; Michael A Nauck; Wolfgang E Schmidt; Juris J Meier
Journal:  Diabetes       Date:  2007-12-05       Impact factor: 9.461

View more
  28 in total

1.  Assessment of pulsatile insulin secretion derived from peripheral plasma C-peptide concentrations by nonparametric stochastic deconvolution.

Authors:  Marcello C Laurenti; Adrian Vella; Ron T Varghese; James C Andrews; Anu Sharma; Nana Esi Kittah; Robert A Rizza; Aleksey Matveyenko; Giuseppe De Nicolao; Claudio Cobelli; Chiara Dalla Man
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-02-26       Impact factor: 4.310

Review 2.  The Continuing Evolution of Precision Health in Type 2 Diabetes: Achievements and Challenges.

Authors:  Yuan Lin; Jennifer Wessel
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

Review 3.  Walking a fine line between β-cell secretion and proliferation.

Authors:  Adrian Vella; Aleksey Matveyenko
Journal:  J Biol Chem       Date:  2018-09-07       Impact factor: 5.157

4.  Glucose tolerance and free fatty acid metabolism in adults with variations in TCF7L2 rs7903146.

Authors:  Jin Lu; Ron T Varghese; Lianzhen Zhou; Adrian Vella; Michael D Jensen
Journal:  Metabolism       Date:  2016-12-09       Impact factor: 8.694

Review 5.  Obstacles to Translating Genotype-Phenotype Correlates in Metabolic Disease.

Authors:  Anu Sharma; Adrian Vella
Journal:  Physiology (Bethesda)       Date:  2017-01

6.  Mechanisms Underlying the Pathogenesis of Isolated Impaired Glucose Tolerance in Humans.

Authors:  Ron T Varghese; Chiara Dalla Man; Anu Sharma; Ivan Viegas; Cristina Barosa; Catia Marques; Meera Shah; John M Miles; Robert A Rizza; John G Jones; Claudio Cobelli; Adrian Vella
Journal:  J Clin Endocrinol Metab       Date:  2016-09-07       Impact factor: 5.958

7.  Diabetes-associated genetic variation in TCF7L2 alters pulsatile insulin secretion in humans.

Authors:  Marcello C Laurenti; Chiara Dalla Man; Ron T Varghese; James C Andrews; Robert A Rizza; Aleksey Matveyenko; Giuseppe De Nicolao; Claudio Cobelli; Adrian Vella
Journal:  JCI Insight       Date:  2020-04-09

8.  Impaired Insulin Action Is Associated With Increased Glucagon Concentrations in Nondiabetic Humans.

Authors:  Anu Sharma; Ron T Varghese; Meera Shah; Chiara Dalla Man; Claudio Cobelli; Robert A Rizza; Kent R Bailey; Adrian Vella
Journal:  J Clin Endocrinol Metab       Date:  2018-01-01       Impact factor: 5.958

9.  Performance of individually measured vs population-based C-peptide kinetics to assess β-cell function in the presence and absence of acute insulin resistance.

Authors:  Ron T Varghese; Chiara Dalla Man; Marcello C Laurenti; Francesca Piccinini; Anu Sharma; Meera Shah; Kent R Bailey; Robert A Rizza; Claudio Cobelli; Adrian Vella
Journal:  Diabetes Obes Metab       Date:  2017-09-27       Impact factor: 6.577

10.  Transcription Factor 7-Like 2 (TCF7L2) Gene Polymorphism and Progression From Single to Multiple Autoantibody Positivity in Individuals at Risk for Type 1 Diabetes.

Authors:  Maria J Redondo; Andrea K Steck; Jay Sosenko; Mark Anderson; Peter Antinozzi; Aaron Michels; John M Wentworth; Mark A Atkinson; Alberto Pugliese; Susan Geyer
Journal:  Diabetes Care       Date:  2018-10-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.